Biostatistics Quiz: One Way Anova
20 questions · exam conditions
0:00
One Way AnovaQuestion 1 of 20

A pharmaceutical company tests four different formulations of a drug on separate groups of patients. The ANOVA results show F(3,28) = 2.45 with p = 0.083. Given that the company had initially hypothesized that Formulation C would be superior to all others, what is the most appropriate interpretation?

Formulation C is significantly superior to all other formulations at α = 0.05
There is insufficient evidence to conclude any differences exist among the formulations at α = 0.05
Formulation C shows a trend toward superiority but requires a larger sample size for confirmation
The results support the hypothesis about Formulation C at α = 0.10 significance level
Post-hoc tests are necessary to determine which specific formulations differ significantly
← Back to quizzes

Biostatistics Quiz

Biostatistics Quiz: One Way Anova

Practice One Way Anova in Biostatistics with focused quiz questions that help you check what you know, review explanations, and build confidence with test-style prompts.

What this quiz covers

This quiz focuses on One Way Anova, giving you a quick way to practice the rules, question types, and explanations that matter most for Biostatistics.

How to use this quiz

Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.

All questions

Question 1

A pharmaceutical company tests four different formulations of a drug on separate groups of patients. The ANOVA results show F(3,28) = 2.45 with p = 0.083. Given that the company had initially hypothesized that Formulation C would be superior to all others, what is the most appropriate interpretation?

  1. Formulation C is significantly superior to all other formulations at α = 0.05
  2. There is insufficient evidence to conclude any differences exist among the formulations at α = 0.05 (correct answer)
  3. Formulation C shows a trend toward superiority but requires a larger sample size for confirmation
  4. The results support the hypothesis about Formulation C at α = 0.10 significance level
  5. Post-hoc tests are necessary to determine which specific formulations differ significantly
Explanation: When you encounter ANOVA results in biostatistics, focus on what the F-statistic and p-value actually tell you about group differences. ANOVA tests the null hypothesis that all group means are equal against the alternative that at least one group differs from the others. Here, F(3,28) = 2.45 with p = 0.083 means there's an 8.3% probability of observing these differences (or greater) if all four formulations were truly equivalent. Since p = 0.083 > 0.05, you fail to reject the null hypothesis at the standard α = 0.05 level. This means there's insufficient statistical evidence to conclude that any meaningful differences exist among the four formulations. Answer B correctly interprets this result. The p-value exceeds the conventional significance threshold, so you cannot conclude differences exist. Answer A is wrong because you cannot claim Formulation C is superior when the overall ANOVA isn't even significant. ANOVA only tells you whether groups differ collectively—it doesn't identify which specific group is best. Answer C incorrectly suggests the results show a "trend" for Formulation C. The company's initial hypothesis about Formulation C is irrelevant to interpreting the ANOVA results, which test overall group differences, not specific formulations. Answer D commits the error of post-hoc significance level adjustment. You cannot change your α level after seeing the results to make them "significant"—this inflates Type I error rates and represents poor statistical practice. Remember: stick to your predetermined α level and interpret ANOVA results for what they test—overall group differences, not specific group superiority.

Question 2

An investigator wants to compare mean cholesterol levels across three dietary interventions. She calculates that with 20 subjects per group, she has 80% power to detect a medium effect size. If she decides to add a fourth intervention group while keeping the same total sample size of 60, what will most likely happen to the statistical power?

  1. Power will increase because more groups provide more information about treatment effects
  2. Power will remain approximately the same because the total sample size is unchanged
  3. Power will decrease because the degrees of freedom for error will be reduced
  4. Power will decrease because each group will have fewer subjects despite the same total N (correct answer)
  5. Power cannot be determined without knowing the specific effect sizes for all groups
Explanation: When you encounter questions about statistical power and study design changes, focus on how modifications affect your ability to detect true differences between groups. Statistical power depends on several factors: effect size, sample size per group, number of comparisons, and alpha level. In ANOVA designs, what matters most for power is having adequate sample size within each group to detect differences between group means. The correct answer is D because changing from 3 groups to 4 groups while keeping the total sample size at 60 reduces each group from 20 subjects to 15 subjects. This 25% reduction in per-group sample size substantially decreases power. Smaller groups have larger standard errors, making it harder to detect true differences between means. The effect is more pronounced than any benefits from additional comparisons. Answer A incorrectly assumes that more groups automatically provide more information. While additional groups can provide more comparisons, they don't increase power when achieved by splitting the same total sample size. Answer B misses the critical insight that total sample size alone doesn't determine power—the distribution of that sample across groups matters enormously. Answer C incorrectly focuses on error degrees of freedom, which actually increase when you add groups (from 57 to 56 error df), and this minor change wouldn't substantially affect power anyway. Study tip: Remember that in ANOVA designs, power primarily depends on sample size per group, not total sample size. When comparing study designs, always calculate the per-group N first—that's usually where you'll find the answer.

Question 3

A clinical trial compares three treatments for depression using standardized mood scores. The sample means are: Treatment A = 68.2, Treatment B = 71.5, Treatment C = 69.8, with an overall mean of 69.8. If the ANOVA F-test is significant (p = 0.032), what can be concluded?

  1. Treatment B is significantly different from both Treatment A and Treatment C
  2. All three treatments differ significantly from each other in their effectiveness
  3. At least one treatment mean differs significantly from at least one other treatment mean (correct answer)
  4. Treatment A is significantly less effective than both other treatments
  5. The difference between the highest and lowest treatment means is statistically significant
Explanation: When you encounter ANOVA results in biostatistics, remember that the F-test tells you whether there's any significant difference among groups, but it doesn't specify which groups differ from each other. The significant ANOVA result (p = 0.032) means we can reject the null hypothesis that all treatment means are equal. This tells us that at least one treatment mean differs significantly from at least one other treatment mean, making C correct. Think of ANOVA as a screening test - it detects the presence of differences but doesn't pinpoint their location. Option A is wrong because ANOVA alone cannot tell us that Treatment B differs from both A and C specifically. While B has the highest mean (71.5), we'd need post-hoc tests like Tukey's HSD to determine which pairwise comparisons are significant. Option B makes an even stronger claim that's unsupported - that all three treatments differ from each other. Again, this would require multiple comparison testing to verify. Option D assumes Treatment A (68.2) is significantly lower than both others, but ANOVA doesn't provide this level of detail about specific comparisons. Notice that the overall mean (69.8) equals Treatment C's mean, which makes sense given the sample sizes, but this doesn't affect the ANOVA interpretation. Study tip: Always remember that a significant ANOVA F-test is like a smoke detector - it tells you there's a fire somewhere in the building, but you need additional tests (post-hoc comparisons) to find exactly where the fire is located.

Question 4

A nutrition researcher conducts a one-way ANOVA to compare vitamin D levels across four seasonal groups (Winter, Spring, Summer, Fall). The analysis reveals F(3,76) = 6.42, p = 0.001. The researcher's next step should be to:

  1. Conclude that all four seasons have significantly different vitamin D levels
  2. Perform post-hoc multiple comparison tests to identify which seasons differ significantly (correct answer)
  3. Repeat the analysis with a more conservative significance level due to multiple comparisons
  4. Calculate effect size measures since the result is statistically significant
  5. Conduct separate t-tests between each pair of seasons to identify specific differences
Explanation: When you encounter a significant one-way ANOVA result, remember that ANOVA only tells you whether there's any difference among the groups—it doesn't specify which groups actually differ from each other. This is a crucial distinction in interpreting ANOVA results. The significant F-statistic (F(3,76) = 6.42, p = 0.001) indicates that vitamin D levels are not equal across all four seasons, but this omnibus test doesn't reveal the specific pattern of differences. To identify which seasonal comparisons are significant (Winter vs. Spring, Summer vs. Fall, etc.), you need post-hoc multiple comparison tests like Tukey's HSD or Bonferroni corrections. This makes B the correct next step. A is wrong because a significant ANOVA doesn't mean all groups differ from each other—it could be that only one season differs from the others, or any other combination of differences. C misunderstands the multiple comparisons issue; the ANOVA itself doesn't require a more conservative alpha level, but the post-hoc tests will handle the multiple comparisons problem through their built-in adjustments. D, while potentially useful, isn't the logical next step when you haven't yet identified which specific groups are driving the significant result. Study tip: Remember the ANOVA sequence: significant omnibus test → post-hoc comparisons → then interpret specific differences. Never conclude that all groups differ based solely on a significant F-test—ANOVA is like a smoke detector that tells you there's a fire somewhere, but not where the fire is located.

Question 5

An ANOVA comparing four drug treatments shows significant results: F(3,36) = 4.85, p = 0.007. The group means are 23.4, 27.8, 25.1, and 29.2. If the researcher performs Tukey's HSD post-hoc test and finds that only the comparison between the first and fourth groups is significant, what conclusion is most appropriate?

  1. The significant ANOVA result was due entirely to the difference between groups 1 and 4 (correct answer)
  2. Groups 2 and 3 have means that are not significantly different from any other group
  3. The post-hoc test contradicts the ANOVA results since only one comparison is significant
  4. Additional post-hoc tests should be performed to verify the Tukey HSD results
  5. The power of the study was insufficient to detect other significant differences
Explanation: When you encounter ANOVA followed by post-hoc tests, you're examining which specific group differences drive an overall significant result. ANOVA tells you that somewhere among your groups there's a significant difference, but post-hoc tests pinpoint exactly where those differences lie. The significant ANOVA result (F(3,36) = 4.85, p = 0.007) indicates that not all four group means are equal. Looking at the means (23.4, 27.8, 25.1, 29.2), you can see the largest difference is between groups 1 and 4 (a 5.8-point gap). When Tukey's HSD finds only this comparison significant, it means this single large difference was sufficient to make the overall ANOVA significant. Answer A correctly identifies that the significant ANOVA resulted entirely from the group 1 vs. group 4 difference. Answer B is incorrect because while groups 2 and 3 aren't significantly different from each other, we don't know their relationship to groups 1 and 4 without seeing those specific comparisons. Answer C misunderstands how ANOVA and post-hoc tests work together—it's perfectly normal for ANOVA to be significant due to just one large difference among multiple comparisons. Answer D suggests unnecessary additional testing when Tukey's HSD already provides comprehensive pairwise comparisons with appropriate error rate control. Remember: A significant ANOVA can result from just one large difference between groups, even when other group differences aren't significant. Post-hoc tests don't contradict ANOVA—they explain what's driving the significant result.

Question 6

A medical researcher compares pain relief scores across three analgesic medications using ANOVA. The between-groups sum of squares is 156.8, within-groups sum of squares is 284.2, with 15 patients per medication group. What percentage of the total variance in pain relief scores is explained by the medication type?

  1. 35.6% (correct answer)
  2. 55.2%
  3. 64.4%
  4. 44.8%
  5. 28.7%
Explanation: When you encounter ANOVA results asking about "variance explained," you're being tested on the coefficient of determination (R²) - a fundamental measure of how much variability in your outcome variable is attributable to group differences. To calculate R², you need the ratio of between-groups sum of squares to total sum of squares. First, find the total sum of squares: SStotal=SSbetween+SSwithin=156.8+284.2=441SS_{total} = SS_{between} + SS_{within} = 156.8 + 284.2 = 441 Then calculate R²: R2=SSbetweenSStotal=156.8441=0.356=35.6%R² = \frac{SS_{between}}{SS_{total}} = \frac{156.8}{441} = 0.356 = 35.6\% This means 35.6% of the variance in pain relief scores is explained by medication type, making A correct. Let's examine why the other answers are wrong. B (55.2%) would result from incorrectly calculating 284.2515\frac{284.2}{515} - perhaps from adding the sums of squares incorrectly. C (64.4%) might come from using 284.2441\frac{284.2}{441}, which would be calculating the percentage of variance NOT explained by the medication (the error variance). D (44.8%) could result from various computational errors, possibly involving the sample size information unnecessarily. Study tip: Remember that R² in ANOVA always equals SSbetweenSStotal\frac{SS_{between}}{SS_{total}}, and percentages of variance explained typically range from 0-100%. Be suspicious of answers requiring complex calculations involving sample sizes when the question provides sum of squares directly - ANOVA variance components depend on sums of squares, not sample sizes.

Question 7

A psychologist conducts a one-way ANOVA to compare stress levels among nurses working in four different hospital units. The analysis yields F(3,56) = 2.18, p = 0.101. The hospital administrator wants to conclude that all units have equivalent stress levels. What is the most appropriate response?

  1. The conclusion is correct; the non-significant result proves that stress levels are equivalent across units
  2. The conclusion is premature; failure to reject the null hypothesis does not prove equivalence (correct answer)
  3. The conclusion is correct but should be qualified by the confidence interval around the effect size
  4. The conclusion is incorrect; a larger sample size is needed before any conclusions can be drawn
  5. The conclusion is correct; p > 0.05 indicates no clinically meaningful differences exist between units
Explanation: When interpreting ANOVA results, you need to understand the fundamental difference between "failing to reject the null hypothesis" and "proving the null hypothesis is true." This distinction is crucial in statistical inference. The ANOVA result shows F(3,56) = 2.18, p = 0.101. Since p > 0.05, we fail to reject the null hypothesis that all group means are equal. However, this doesn't prove that the groups are actually equivalent—it simply means we don't have sufficient evidence to conclude they're different. The administrator's conclusion commits a logical fallacy by treating "no evidence of difference" as "evidence of no difference." Answer B correctly identifies this reasoning error. Failure to reject the null hypothesis could result from truly equal means, but it could also result from insufficient power, high variability, small effect sizes, or inadequate sample size. Without additional evidence (like equivalence testing), we cannot conclude the groups are equivalent. Answer A makes the classic mistake of interpreting non-significance as proof of equivalence, which is statistically invalid. Answer C suggests the conclusion is correct, which it isn't—confidence intervals around effect sizes don't validate an equivalence claim without proper equivalence testing. Answer D focuses solely on sample size, but the fundamental issue is the logical interpretation error, not necessarily inadequate power. Remember this key principle: in hypothesis testing, non-significant results mean "insufficient evidence for a difference," never "proof of no difference." To demonstrate equivalence, you need specialized equivalence tests, not traditional null hypothesis testing.

Question 8

A researcher plans to conduct a one-way ANOVA to compare mean reaction times across 6 different age groups. She wants to detect a medium effect size (f = 0.25) with 80% power at α = 0.05. If power analysis indicates she needs 25 subjects per group, what would happen to the required sample size if she decided to use α = 0.01 instead?

  1. The required sample size would decrease because the more stringent α reduces Type I error
  2. The required sample size would increase because lower α requires stronger evidence to reject H₀ (correct answer)
  3. The required sample size would remain the same because power depends only on effect size
  4. The required sample size would decrease because Type II error is reduced with smaller α
  5. The effect on sample size cannot be determined without knowing the population variance
Explanation: When you encounter power analysis questions, remember that statistical power depends on four interconnected factors: effect size, sample size, significance level (α), and power itself. Changing any one affects the others. Lowering α from 0.05 to 0.01 makes your significance criterion more stringent—you need stronger evidence to reject the null hypothesis. This creates a trade-off: while you reduce the chance of Type I error (falsely rejecting a true null), you make it harder to detect a true effect. To maintain the same 80% power with this more demanding α level, you must compensate by increasing your sample size to generate stronger evidence. Think of it like raising the bar in high jump—if you set the bar higher (lower α), you need more preparation (larger sample) to clear it with the same success rate (maintain power). Answer B correctly identifies this relationship: lower α requires stronger evidence, necessitating a larger sample size. Answer A incorrectly suggests the opposite relationship and confuses the benefit of reduced Type I error with sample size requirements. Answer C is wrong because power absolutely depends on α—it's one of the four key factors in power analysis. Answer D misunderstands the relationship between Type I and Type II errors; reducing α actually increases Type II error risk unless you compensate with larger samples. Study tip: Remember the power analysis trade-offs with this phrase: "Stricter standards (lower α) demand stronger evidence (larger n) to maintain the same confidence in detecting true effects."

Question 9

A pharmacologist tests four different dosages of a new medication on blood glucose levels. The ANOVA results show F(3,36) = 5.72, p = 0.003. The effect size (eta-squared) is 0.32. How should this result be interpreted in terms of practical significance?

  1. The result is both statistically and practically significant, as 32% of variance is explained
  2. The result is statistically significant but lacks practical significance due to low effect size
  3. The result demonstrates strong practical significance regardless of statistical significance
  4. Practical significance cannot be determined from eta-squared alone; clinical context is needed (correct answer)
  5. The large F-value indicates both statistical and practical significance are present
Explanation: When you encounter questions about practical vs. statistical significance, remember that statistical significance tells you if an effect likely exists, while practical significance tells you if that effect matters in real-world applications. This ANOVA shows clear statistical significance (p = 0.003), meaning the dosage differences are unlikely due to chance. The eta-squared of 0.32 indicates a large effect size by conventional standards (small = 0.01, medium = 0.06, large = 0.14). However, practical significance depends entirely on clinical context that isn't provided here. Answer D is correct because determining practical significance requires knowing what constitutes a clinically meaningful change in blood glucose. A 32% variance explanation could represent either a modest change across a wide range of values or a dramatic change across a narrow range. Without knowing baseline glucose levels, the magnitude of actual changes, or clinical thresholds for meaningful improvement, you cannot assess practical significance. Answer A incorrectly assumes that a large statistical effect size automatically equals practical significance. Answer B makes the opposite error, calling 0.32 a "low effect size" when it's actually quite large by statistical conventions. Answer C wrongly suggests practical significance exists independent of statistical significance, when both are needed for meaningful clinical conclusions. Study tip: In biostatistics, always distinguish between statistical measures (p-values, effect sizes) and clinical relevance. Large effect sizes suggest important findings worth investigating, but practical significance always requires domain knowledge about what constitutes meaningful change in the specific clinical context.

Question 10

A researcher conducts a one-way ANOVA comparing memory scores across three age groups: Young (20-30 years), Middle-aged (40-50 years), and Elderly (65-75 years). Before analyzing the data, she should be most concerned about which potential violation of ANOVA assumptions?

  1. Independence of observations within each age group
  2. Normality of memory scores within each age group
  3. Homogeneity of variance across the three age groups (correct answer)
  4. Random sampling from each age population
  5. Equal sample sizes across the three age groups
Explanation: When you encounter ANOVA questions, always consider which assumptions are most critical and likely to be violated in the given scenario. ANOVA has four key assumptions: independence, normality, homogeneity of variance, and random sampling. The correct answer is C because homogeneity of variance (homoscedasticity) is the assumption most likely to be problematic when comparing different age groups on cognitive measures like memory. Age groups naturally tend to show different amounts of variability in performance - younger adults typically show more consistent scores clustered around higher values, while elderly participants often display much greater variability due to factors like varying degrees of cognitive decline, health differences, and medication effects. This creates unequal variances across groups, violating the homoscedasticity assumption. A is less concerning because independence within age groups is typically maintained through proper experimental design and random assignment. B (normality) is important but ANOVA is relatively robust to normality violations, especially with reasonable sample sizes. D (random sampling) is a design issue that should be addressed during study planning, but it's not the assumption you'd be "most concerned about" when you're ready to analyze existing data. ANOVA is particularly sensitive to variance inequality when group sizes are unequal, and this violation can seriously affect the validity of your results and increase Type I error rates. Study tip: For biostatistics exams, remember that when comparing groups that naturally differ in variability (age groups, disease severity levels, treatment vs. control), homogeneity of variance is usually your biggest statistical concern.

Question 11

In a one-way ANOVA with unequal group sizes (n₁ = 8, n₂ = 12, n₃ = 15), a researcher finds F(2,32) = 3.89, p = 0.031. When checking assumptions, she discovers that the group with the smallest sample size has the largest variance. What is the most likely consequence for the ANOVA results?

  1. The F-test will be more conservative, reducing the chance of Type I error below the nominal α level (correct answer)
  2. The F-test will be more liberal, increasing the chance of Type I error above the nominal α level
  3. The unequal sample sizes will automatically correct for the heteroscedasticity problem
  4. The F-test remains robust because the total sample size is adequate for the analysis
  5. The direction of bias cannot be determined without knowing the exact variance values
Explanation: When you encounter ANOVA questions involving assumption violations, focus on how heteroscedasticity (unequal variances) combined with unequal sample sizes affects the F-test's behavior. The key insight here is understanding the relationship between sample size and variance in ANOVA. When the smallest group (n₁ = 8) has the largest variance, this creates a specific pattern that makes the F-test more conservative. The F-statistic becomes less sensitive to detecting true differences because the high-variance group contributes less weight to the overall analysis due to its small sample size. This reduces the actual Type I error rate below the nominal α level (typically 0.05), meaning you're less likely to falsely reject the null hypothesis than your significance level suggests. Option A is correct because this variance-sample size pattern consistently produces conservative results. Option B represents the opposite scenario—if the largest group had the largest variance, the test would become liberal and inflate Type I error rates. Option C incorrectly suggests that unequal sample sizes somehow automatically fix heteroscedasticity; they don't—the combination actually creates the problem. Option D wrongly assumes that adequate total sample size (35 participants) guarantees robustness regardless of assumption violations, but ANOVA's robustness depends heavily on the specific pattern of variance and sample size relationships. Study tip: Remember the critical pattern: small n + large variance = conservative test (Type I error below α); large n + large variance = liberal test (Type I error above α). This relationship appears frequently on biostatistics exams when testing ANOVA assumption knowledge.

Question 12

An ANOVA comparing four different teaching methods yields SSTotal = 850, SSBetween = 340, and SSWithin = 510. With 8 students per method, the researcher concludes that the teaching methods differ significantly (p < 0.05). However, a colleague notes an error in the calculation. What is the most likely problem?

  1. SSBetween + SSWithin should equal SSTotal, but 340 + 510 = 850, so the calculations appear correct (correct answer)
  2. The degrees of freedom calculation is incorrect because there are only 31 total degrees of freedom
  3. SSBetween + SSWithin = 850, but this exceeds SSTotal, indicating a computational error
  4. The F-statistic calculation used the wrong formula for the mean squares
  5. The sample size is too small to achieve significance with these sum of squares values
Explanation: When you encounter ANOVA problems, always start by checking the fundamental relationship: SSTotal=SSBetween+SSWithinSS_{Total} = SS_{Between} + SS_{Within}. This partitioning of variance is the foundation of analysis of variance. Let's verify the calculations: SSBetween+SSWithin=340+510=850SS_{Between} + SS_{Within} = 340 + 510 = 850, which exactly equals SSTotal=850SS_{Total} = 850. This confirms the sum of squares calculations are mathematically correct. However, the question states there's an error, making this a tricky problem that tests your understanding of what can go wrong beyond basic arithmetic. Looking at the answer choices: Choice A correctly identifies that the calculations appear arithmetically sound, which is the most likely "problem" the colleague noticed - there's actually no computational error in the given values. Choice B incorrectly suggests 31 total degrees of freedom, but with 32 students total (8 per group × 4 groups), there are actually 31 total degrees of freedom, making this calculation correct. Choice C contains a logical error - it states that 850 exceeds SSTotalSS_{Total}, but 850 equals SSTotalSS_{Total}, not exceeds it. Choice D assumes an F-statistic error, but we can't determine this from the given information since the F-statistic could be calculated correctly from these sum of squares values. The key insight is that this question tests whether you'll second-guess correct calculations when told there's an error. Sometimes in statistics, what appears to be an error actually isn't - always verify the fundamental relationships first before assuming computational mistakes.

Question 13

A researcher studying the effect of three different exercise programs on weight loss finds the following group variances: Program A: s² = 12.4, Program B: s² = 18.7, Program C: s² = 9.2. Before proceeding with ANOVA, what should be the researcher's primary concern?

  1. The sample sizes in each group may be too small for reliable variance estimates
  2. The ratio of largest to smallest variance exceeds 2:1, suggesting possible heteroscedasticity (correct answer)
  3. The variances should be more similar for the ANOVA to be valid and interpretable
  4. A formal test for equality of variances should be conducted before proceeding
  5. The mean differences may be confounded with the variance differences
Explanation: When you encounter ANOVA questions involving multiple group variances, you need to evaluate whether the assumption of homoscedasticity (equal variances) is reasonably met before proceeding with the analysis. Let's examine these variances systematically. The largest variance is Program B at 18.7, and the smallest is Program C at 9.2. The ratio of largest to smallest variance is 18.79.2=2.03\frac{18.7}{9.2} = 2.03, which exceeds the commonly used 2:1 rule of thumb for ANOVA. This suggests potential heteroscedasticity (unequal variances), which violates a key ANOVA assumption and can lead to unreliable results. Choice A is incorrect because the concern isn't about sample size adequacy for variance estimation—we're given actual variance values to work with. Choice C is too vague and doesn't provide the specific guidance needed; while variances should be "similar," it doesn't tell you how to quantify "similar enough." Choice D suggests conducting a formal test, but this is often unnecessary when you can apply the practical 2:1 rule, and formal tests like Levene's test can be overly sensitive with large samples. Choice B correctly identifies the specific problem: the variance ratio exceeds 2:1, indicating possible heteroscedasticity. This rule of thumb is widely used because when the largest variance is more than twice the smallest, ANOVA results become less reliable, especially with unequal sample sizes. Study tip: Remember the 2:1 variance ratio rule for ANOVA. Calculate largest variance ÷ smallest variance—if it exceeds 2.0, consider this a red flag for heteroscedasticity before proceeding with standard ANOVA.

Question 14

A researcher conducts a one-way ANOVA to compare the mean blood pressure reduction among four different antihypertensive medications. The F-statistic is 3.24 with 3 degrees of freedom in the numerator and 36 degrees of freedom in the denominator. If the critical value at α = 0.05 is 2.87, which conclusion is most appropriate?

  1. Accept the null hypothesis; there is insufficient evidence of differences among the medication means
  2. Reject the null hypothesis; at least one medication mean differs significantly from the others (correct answer)
  3. Accept the alternative hypothesis; all medication means are significantly different from each other
  4. Reject the null hypothesis; exactly one medication mean differs significantly from the others
  5. The test is inconclusive; additional post-hoc testing is required before drawing conclusions
Explanation: When you encounter a one-way ANOVA question, you're dealing with hypothesis testing that compares means across multiple groups. The null hypothesis states that all group means are equal, while the alternative hypothesis states that at least one mean differs from the others. The decision rule is straightforward: compare your calculated F-statistic to the critical value. Here, your F-statistic is 3.24 and the critical value is 2.87. Since 3.24 > 2.87, you reject the null hypothesis. This means there's sufficient evidence that at least one medication produces a different mean blood pressure reduction than the others. Option A is incorrect because when your test statistic exceeds the critical value, you have sufficient evidence to reject the null hypothesis, not accept it. Option C makes a critical error in interpretation—rejecting the null hypothesis in ANOVA only tells you that at least one mean differs, not that all means are different from each other. You'd need post-hoc tests to determine which specific pairs differ. Option D is also wrong because ANOVA doesn't tell you exactly how many means differ, only that at least one does. Option B correctly states that you reject the null hypothesis and that at least one medication mean differs significantly from the others—this is precisely what a significant ANOVA result indicates. Remember: ANOVA is like a screening test. A significant result tells you differences exist somewhere among your groups, but you need additional pairwise comparisons to pinpoint exactly where those differences lie.

Question 15

In a one-way ANOVA with 3 groups and 45 total observations, SSTotal = 890.5 and SSWithin = 623.8. If the calculated F-statistic is 8.94, what is the most likely error in the analysis?

  1. The degrees of freedom for the denominator should be 44, not 42
  2. SSBetween was calculated incorrectly as it should equal SSTotal - SSWithin
  3. The F-statistic calculation used the wrong mean square values
  4. The total degrees of freedom should be 45, not 44
  5. No error is apparent; the calculations appear consistent with the given values (correct answer)
Explanation: When you encounter one-way ANOVA problems, always verify the calculations systematically by checking each component against the given information. Let's work through this step-by-step. With 3 groups and 45 total observations, we have:
  • Between groups df = k-1 = 3-1 = 2
  • Within groups df = N-k = 45-3 = 42
  • Total df = N-1 = 45-1 = 44
First, calculate SSBetween: SSBetween=SSTotal−SSWithin=890.5−623.8=266.7SSBetween = SSTotal - SSWithin = 890.5 - 623.8 = 266.7 Next, find the mean squares:
  • MSBetween=SSBetweendfbetween=266.72=133.35MSBetween = \frac{SSBetween}{df_{between}} = \frac{266.7}{2} = 133.35
  • MSWithin=SSWithindfwithin=623.842=14.85MSWithin = \frac{SSWithin}{df_{within}} = \frac{623.8}{42} = 14.85
Finally, calculate F: F=MSBetweenMSWithin=133.3514.85=8.98F = \frac{MSBetween}{MSWithin} = \frac{133.35}{14.85} = 8.98 This matches the given F-statistic of 8.94 (allowing for rounding differences), indicating no error exists in the analysis. Answer choice A is incorrect because the within groups df is correctly 42 (N-k = 45-3). Answer B is wrong since SSBetween does equal SSTotal - SSWithin. Answer C is incorrect because the mean square values and F-statistic calculation are proper. Answer D is wrong because total df correctly equals N-1 = 44. Study tip: Always double-check ANOVA calculations by working backwards from the F-statistic. If your recalculated F matches the given value, the analysis is likely correct. Practice identifying when "no error" might be the right answer rather than assuming something must be wrong.

Question 16

In a one-way ANOVA with 5 groups and 12 observations per group, a researcher obtains an F-statistic of 2.89. She wants to determine if this result is statistically significant at α = 0.05. What degrees of freedom should she use to find the critical value?

  1. df = 4, 55 (correct answer)
  2. df = 5, 60
  3. df = 4, 59
  4. df = 5, 55
  5. df = 59, 4
Explanation: When you encounter ANOVA F-test questions, you need to identify the correct degrees of freedom for both the numerator and denominator to find the critical value from the F-distribution table. For one-way ANOVA, the degrees of freedom follow specific formulas. The numerator degrees of freedom (between groups) equals k−1k - 1, where kk is the number of groups. With 5 groups, this gives you 5−1=45 - 1 = 4. The denominator degrees of freedom (within groups/error) equals N−kN - k, where NN is the total sample size. With 5 groups of 12 observations each, N=60N = 60, so the denominator df is 60−5=5560 - 5 = 55. Therefore, you need df=4,55df = 4, 55. Looking at the wrong answers: Choice B (5, 60) incorrectly uses the number of groups as the numerator df instead of subtracting 1, and uses the total sample size as the denominator df without subtracting the number of groups. Choice C (4, 59) gets the numerator correct but miscalculates the denominator—this might result from incorrectly using N−1N - 1 instead of N−kN - k. Choice D (5, 55) correctly calculates the denominator but fails to subtract 1 from the number of groups for the numerator. Study tip: Memorize the ANOVA df formulas: numerator = k−1k - 1 (groups minus 1), denominator = N−kN - k (total observations minus groups). Always double-check your total sample size calculation when groups have equal sizes.

Question 17

A researcher compares the effectiveness of three physical therapy techniques on pain reduction scores. The ANOVA table shows MSB = 45.6 and MSW = 12.3. If there are 10 patients in each group, what assumption is most critical to verify before interpreting these results?

  1. The pain scores follow a normal distribution within each treatment group
  2. The three treatment groups have equal variances in their pain scores (correct answer)
  3. The patients were randomly assigned to the three treatment groups
  4. The pain reduction scores are measured on an interval or ratio scale
  5. The sample size of 10 per group provides adequate power for the analysis
Explanation: When you encounter ANOVA problems in biostatistics, you're dealing with a statistical test that compares means across multiple groups. ANOVA has several key assumptions, but their relative importance depends on factors like sample size and the robustness of the test to violations. The correct answer is B because equal variances (homoscedasticity) is the most critical assumption to verify here. With only 10 patients per group, ANOVA is particularly sensitive to variance differences between groups. Unequal variances can dramatically inflate Type I error rates and make your F-statistic unreliable. The fact that you're given MSB and MSW values suggests the focus is on variance-related calculations, reinforcing this assumption's importance. Let's examine why the other options are less critical: A is incorrect because ANOVA is remarkably robust to normality violations, especially with equal sample sizes of 10 per group. The Central Limit Theorem helps here, and F-tests can tolerate non-normal data quite well. C is wrong because random assignment affects external validity and causal inference, but it's not a statistical assumption required for ANOVA calculations themselves. D is incorrect because while measurement scale matters, most pain scores in research already meet interval/ratio requirements, and this is typically established during study design rather than being verified post-hoc. Study tip: Remember that with smaller sample sizes (like n=10 per group), focus on the equal variances assumption first. Use Levene's test or examine residual plots before interpreting your ANOVA results. ANOVA forgives normality violations more easily than variance violations.

Question 18

A researcher performs a one-way ANOVA comparing mean cholesterol levels across three diet groups and obtains a significant F-statistic (F = 4.82, p = 0.015). The group means are: Diet A = 180 mg/dL, Diet B = 165 mg/dL, Diet C = 195 mg/dL. If the researcher concludes that 'Diet B is significantly better than Diet C,' what error has been made?

  1. No error; the significant ANOVA indicates Diet B is significantly different from Diet C
  2. The error is concluding causation when only correlation has been established by the ANOVA
  3. The error is making pairwise comparisons without post-hoc testing after a significant omnibus test (correct answer)
  4. The error is interpreting statistical significance as clinical significance without effect size consideration
Explanation: A significant omnibus F-test only indicates that at least one group differs from the others, but does not specify which pairs are significantly different. To make claims about specific pairwise comparisons (like Diet B vs. Diet C), post-hoc tests (such as Tukey's HSD, Bonferroni, or Scheffe) must be conducted to control for multiple comparisons and maintain the overall Type I error rate.

Question 19

A researcher conducts a one-way ANOVA to compare mean blood pressure across four treatment groups (n = 12 per group). The calculated F-statistic is 2.95. If the critical value at α = 0.05 is 2.84, but the researcher mistakenly uses the critical value for α = 0.01 (which is 4.31) to make their decision, what type of error becomes more likely and what is the immediate consequence for their conclusion?

  1. Type I error becomes more likely; they will incorrectly reject the null hypothesis
  2. Type II error becomes more likely; they will incorrectly fail to reject the null hypothesis (correct answer)
  3. Type I error becomes more likely; they will incorrectly fail to reject the null hypothesis
  4. Type II error becomes more likely; they will incorrectly reject the null hypothesis
Explanation: The calculated F-statistic (2.95) exceeds the correct critical value at α = 0.05 (2.84), so the null hypothesis should be rejected. However, by mistakenly using the more stringent critical value for α = 0.01 (4.31), the researcher will fail to reject the null hypothesis since 2.95 < 4.31. This increases the probability of Type II error (failing to reject a false null hypothesis). The immediate consequence is incorrectly concluding no difference exists when one actually does.

Question 20

A researcher conducts a one-way ANOVA with 5 groups and obtains F = 2.85. If the total sample size is 40, what are the degrees of freedom and what additional information is needed to determine statistical significance at α = 0.05?

  1. df₁ = 4, df₂ = 35; no additional information needed since F exceeds most critical values at α = 0.05
  2. df₁ = 5, df₂ = 39; the critical value from F-distribution tables is needed for comparison
  3. df₁ = 4, df₂ = 35; the critical value from F-distribution tables is needed for comparison (correct answer)
  4. df₁ = 4, df₂ = 35; the p-value calculation requires the mean square values from the ANOVA table
Explanation: With k=5 groups and n=40 total: df₁ = k-1 = 4, df₂ = n-k = 35. To determine significance, the calculated F-statistic (2.85) must be compared to the critical F-value from tables at α = 0.05 with df₁ = 4 and df₂ = 35. The critical value (approximately 2.64) is needed to make the decision. Choice A incorrectly assumes significance without proper comparison.